[Skip to Navigation]
Sign In
Editor's Correspondence
December 9/23, 2002

Risk of Myocardial Infarction Associated With Selective COX-2 Inhibitors: Questions Remain—Reply

Arch Intern Med. 2002;162(22):2641. doi:

In reply

Two clinical trials found that the incidence of MI in those who use rofecoxib was similar to that in those who use ibuprofen or diclofenac.1,2 The VIGOR study found an increased risk of MI with rofecoxib compared with naproxen.3

Add or change institution
×